Faraday Pharmaceuticals is a therapeutics company focused treating ischemia-reperfusion injury. Founded by Christopher Toombs in 2014, Faraday Pharmaceuticals is backed by investors that include ARCH Venture Partners, OUP (Osage University Partners), Polaris Partners, and Washington Research Foundation. and is headquartered in Seattle.